Rong S, Segal S, Anver M, Resau J H, Vande Woude G F
Advanced BioScience Laboratories-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702.
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4731-5. doi: 10.1073/pnas.91.11.4731.
The met protooncogene product, Met, is the tyrosine kinase growth factor receptor for hepatocyte growth factor/scatter factor (HGF/SF). NIH 3T3 cells express HGF/SF endogenously and become tumorigenic in nude mice via an autocrine mechanism when murine Met is expressed ectopically (Metmu cells) or when human Met and human HGF/SF are coexpressed (HMH cells). Here, we show that Metmu and HMH cells are invasive in vitro and display enhanced protease activity necessary for the invasive phenotype. In experimental and spontaneous metastasis assays, Metmu or HMH cells metastasize to the lung, but lower numbers of subcutaneously injected Metmu and HMH cells produced invasive tumors in the heart, diaphragm, salivary gland, and retroperitoneum. It has been reported elsewhere that Met expression increased with tumor passage in athymic nude mice, and these tumor explants show enhanced activity in the metastasis assays. Autocrine-mediated Met-HGF/SF signal transduction in NIH 3T3 mesenchymal cells may provide an important system for understanding the biological process of metastasis.
原癌基因Met的产物Met是肝细胞生长因子/分散因子(HGF/SF)的酪氨酸激酶生长因子受体。NIH 3T3细胞内源性表达HGF/SF,当异位表达鼠源Met(Metmu细胞)或共表达人源Met和人源HGF/SF(HMH细胞)时,通过自分泌机制在裸鼠体内具有致瘤性。在此,我们表明Metmu和HMH细胞在体外具有侵袭性,并表现出侵袭表型所需的增强的蛋白酶活性。在实验性和自发性转移试验中,Metmu或HMH细胞转移至肺部,但皮下注射的Metmu和HMH细胞数量较少时,在心脏、膈肌、唾液腺和腹膜后产生侵袭性肿瘤。其他地方已有报道,在无胸腺裸鼠中,Met表达随肿瘤传代而增加,并且这些肿瘤外植体在转移试验中表现出增强的活性。NIH 3T3间充质细胞中自分泌介导的Met-HGF/SF信号转导可能为理解转移的生物学过程提供一个重要的系统。